T2EC are chicken erythrocytic progenitors that balance between self-renewal and dierentiation as a function of response to speci®c growth factors. Their transformation by the v-erbA oncogene locks them into the self-renewal program. We show here that the expression of the VLA-2 integrin a2 subunit mRNA is downregulated by v-erbA and that VLA-2 engagement and clustering, brought about by treatment with an a2-speci®c antibody or by culture on the VLA-2 ligand collagen I, inhibits T2EC proliferation. From competition studies using antibodies, VLA-2 was shown to be involved in the collagen-induced response. While engagement of VLA-2 inhibited proliferation, it was not sucient to induce dierentiation. The transformation of T2EC by v-erbA decreased their interaction with collagen I and the VLA-2 brake on cell proliferation, which may account for the increased proliferation potential of transformed erythrocytic progenitors and for their shedding into the blood of infected chickens. Our data suggest that the interaction between erythroid progenitors and collagen, mediated by VLA-2, play a major role in the control of erythropoiesis in vitro and that this pathway is a target of the v-erbA oncogene.
Introduction
In most adult vertebrates and under steady state conditions, erythropoiesis takes place in bone marrow and depends on the interaction of hematopoietic progenitors with their microenvironment made of stromal cells, cytokines and extracellular matrix proteins (Dorshkind, 1990; Whetton and Spooncer, 1998; Yoder and Williams, 1995) such as ®bronectins, collagens, laminins, proteoglycans (Bentley and Foidart, 1980; Bentley, 1982; Spooncer et al., 1983; Zuckerman and Wicha, 1983) and others (Yoder and Williams, 1995) . In this network, adhesion molecules appear as crucial regulators. First, they retain hematopoietic progenitors in a favorable environment (Lemischka, 1997) . Secondly, the contact interactions between progenitors and marrow stromal ligands, particularly through members of the integrin family, trigger signal transduction pathways (Kumar, 1998 ) that modulate cell growth (Howe et al., 1998) and regulate hematopoiesis (Coulombel et al., 1997) .
To gain further insight into the mechanisms involved in erythropoiesis our laboratory has developed a unique model of single lineage, normal erythrocytic progenitors, the T2EC (TGFa TGFb induced Erythrocytic Cells). These cells were isolated from chicken bone marrow and maintained in an undierentiated state in vitro by cultivation in a medium containing both TGFa and TGFb. In the absence of these growth factors T2EC can be induced to dierentiate into erythroblasts by culture in an inducing medium (Gandrillon et al., 1999) .
Chicken infection with the avian erythroblastosis virus (AEV) induces sarcomas (Graf and Beug, 1978) and erythroleukemia (Samarut and Gazzolo, 1982) . In vitro the infection of erythrocytic progenitors by AEV transforms these cells by blocking their dierentiation at the CFU-E stage (Samarut and Gazzolo, 1982) . The genomic of AEV shares two oncogenes, v-erbB and verbA (Graf and Beug, 1978) , but the expression of verbA alone reproduces the AEV dierentiation blockade of erythrocytic progenitors in vitro (Gandrillon et al., 1989) . The v-erbA oncogene was transduced by the erythroblastosis virus from the cellular gene c-erbA encoding the nuclear receptor for the thyroid hormone triiodothyronine (Sap et al., 1986) . It is expressed as a gag v-erbA fusion protein that binds to the DNA but does not bind the hormone (Sap et al., 1986; Boucher et al., 1988) . V-erbA may therefore act at the transcriptional level by dysregulating the expression of target genes and perturbing the major mechanisms controlling the balance between the self-renewal and the commitment toward dierentiation of erythrocytic progenitors.
In this work we observed that T2EC expressing verbA show alterations of membrane antigen expression suggesting that the dierentiation blockade may be, at least in part, dependent on alterations in the interactions of these cells with their environment. This approach led us to identify the VLA-2 (a2b1) integrin, a member of the b1 integrin family, as a new target of v-erbA. Our results describe a novel role for VLA-2 and its major ligand, type I collagen, in the proliferation of erythrocytic progenitors.
Results

VLA-2 expression is downregulated by the v-erbA oncogene
To identify membrane antigens whose expression might be altered by the v-erbA oncogene we used several monoclonal antibodies produced against chicken cells of hematopoietic origin (McNagny et al., 1992; Schmidt et al., 1986) . The expression levels of their corresponding antigens was measured by¯ow cytometry and compared between T2EC infected with the XJ12 retrovirus vector carrying the v-erbA gene and T2EC infected with the control retrovirus TXN. Among them the VLA-2 integrin a-2 subunit, detected by the MEP17 antibody (Bradshaw et al., 1995) decreased markedly after infection by the v-erbA carrying virus ( Figure 1A ).
The VLA-2 integrin is a heterodimeric transmembrane glycoprotein consisting of an a2 subunit associated with a b1 subunit common to other members of this integrin family. Because VLA-2 membrane expression is dependent on this heterodimerization , the observed downregulation of the a2 subunit might be an indirect consequence of a b1 downregulation. Figure 1B shows that the b1 subunit detected by the JG22 antibody (Greve and Gottlieb, 1982; Buck et al., 1986) was strongly expressed on the surface of about 80% of T2EC. While infection with v-erbA viruses lowered the b1¯uorescence by 39%, the bulk of the cells remained b1 positive. In contrast, VLA-2¯uorescence decreased 74% and the per cent of labeled cells fell 79% in verbA infected cells ( Figure 1A) . Thus, the marked down-modulation of VLA-2 by v-erbA cannot be accounted for by a global repression of all b1 integrins. Rather, the modest decrease in b1 expression probably re¯ects the decreased levels of a2 dimerization partners.
Down modulation of a2 subunit RNAs expression by v-erbA
To determine if v-erbA controls the expression of the a2 subunit gene, the expression of a2 subunit mRNAs was assessed by ribonuclease protection assay. As shown in Figure 2 , a2 subunit RNA content was strongly decreased in XJ12 when compared with TXN infected cells; a dierence that was not observed with the GAPDH probe used as control.
Adhesion of T2EC to collagen and to fibronectin
The VLA-2 integrin is a collagen receptor or a mixed collagen/laminin receptor depending on the expressing cell type (Kirchhofer et al., 1990) . VLA-4 and VLA-5 integrins, which are strongly expressed on mouse P-labeled anti-sense RNA probes speci®c for the integrin a2-subunit and for GAPDH used as control. RNA extracted from TXN or XJ12 infected T2EC was hybridized with a mixture of both probes. The ribonuclease-protected fragments were separated by acrylamide gel electrophoresis and the gel was exposed to intensifying screens for 3 h for GAPDH and for 3 days for VLA-2. One experiment representative of two performed on independent RNA preparations is shown (Williams et al., 1991) and human (Teixido et al., 1992; Kerst et al., 1993) hematopoietic progenitors, function as ®bronectin receptors. In accordance with previous reports on human BFU-E (Koenigsmann et al., 1992) and mouse CFU-E (Goltry and Patel, 1997), T2EC adhere to type I collagen in a dose-dependent manner, requiring collagen I coating-concentrations between 1.25 and 5 mg/ml (Figure 3 ). The adhesion of T2EC to ®bronectin was less sensitive than to type I collagen and required coating-concentrations ranging from 10 to 20 mg/ml (Figure 3) . When compared to the maximal adhesion on poly-L-lysine, the mean binding of T2EC to collagen and to ®bronectin reached 48 and 8% respectively of the total cells added (see Figure 5B ).
Inhibition of T2EC adhesion to collagen type I or to fibronectin by anti-a2, anti-b1 or divalent cation chelation Integrin-mediated ligand binding requires divalent cations such as Ca 2+ or Mg 2+ (Hynes, 1987) . To con®rm the involvement of integrins in T2EC interactions with ®bronectin or type I collagen, adhesion studies were performed in the presence of EDTA or the MEP17 and JG22 antibodies used as blocking antibodies as previously described (Bradshaw et al., 1995) . The VLA-2 integrin was strongly involved in the interaction of T2EC with collagen since MEP17 inhibited cell adhesion by almost 50%. In contrast adhesion to collagen was much less inhibited by chelation of divalent cations ( Figure 4 ). As expected, the interaction with ®bronectin was not aected by MEP17, but was mostly cation-dependent (62% inhibition in the presence of EDTA) suggesting that integrins may be strongly involved in interaction with ®bronectin as previously reported for hematopoietic progenitors (Williams et al., 1991; Goltry and Patel, 1997) . The anti-b1 antibody, JG22, decreased T2EC adhesion to ®bronectin by 45% while it poorly abrogated the interaction with type I collagen ( Figure  4 ). This lower eciency of JG22 on collagen than on ®bronectin may re¯ect a lower anity due to a more restricted access of this subunit in the dierent integrins engaged.
Expression of v-erbA decreases adhesion of T2EC to type I collagen
Consistent with results obtained with XJ12 infected T2EC expressing v-erbA only, the infection of T2EC with AEV expressing both v-erbA and v-erbB markedly decreased the membrane VLA-2 while the S61G-infected cells, expressing a mutant version of v-erbA defective in its ability to inhibit dierentiation (Bauer et al., 1997) , expressed the same level of VLA-2 as TXN infected cells ( Figure 5A ). Consequently, the expression of v-erbA in XJ12 or AEV infected T2EC strongly impaired their ability to bind type I collagen ( Figure 5B ) and this property correlates with v-erbA transforming activity.
Role of VLA-2 in extracellular matrix-dependent inhibition of T2EC proliferation
Ligand binding to integrins triggers their clustering and subsequent activation of intracellular signal pathways. To explore the consequences of T2EC interaction with VLA-2, T2EC were induced to proliferate in wells coated with type I collagen at a concentration giving maximal binding (see Figure 3 ). As control we used wells coated with heat denatured BSA. Collagen I inhibited T2EC proliferation by 23% whereas inhibition by BSA was only 7% (Figure 6 ). To assess the role of VLA-2 and other b1-integrins in this process, competition experiments were performed with the soluble forms of MEP17 and JG22 antibodies. When cultivated on plates coated with type I collagen the VLA-2 is involved in adhesion of T2EC to type I collagen but not to ®bronectin. Competition experiments were performed in wells coated with type I collagen (5 mg/ml) or ®bronectin (20 mg/ml) with T2EC pre-incubated 1 h at room temperature with competitors before addition of the mixtures to the substrates. The MEP17 antibody (anti-a2, 10 mg/ml) and the JG22 antibody (anti-b1, 50 mg/ml) were used as a competitor and mouse myeloma IgG1 (50 mg/ml) was used as control antibody. EDTA was used at 5 mM. Cells pre-incubated with no competitor were considered as giving the maximal binding and used for calculation of the per cent of binding-inhibition. Results presented are the mean+s.e.m. of ®ve separate experiments VLA-2 and v-erbA in erythrocytic progenitor proliferation A Mey et al mixture of MEP17 and JG22 antibodies, but not the antibodies used separately (not shown) nor the control antibody, competed with the matrix induced proliferation inhibition ( Figure 6 ). Under these conditions, collagen-dependent inhibition of proliferation was reduced to basal levels comparable to that observed in control wells coated with heat denatured BSA ( Figure 6 ). None of the antibodies impaired the nonspeci®c proliferation inhibition observed on coated BSA. These data indicate that the VLA-2 integrin is involved in the control of T2EC self-renewal.
VLA-2 engagement inhibits the proliferation of T2EC
To further explore VLA-2 function, the VLA-2-ligand interaction was mimicked by antibody-mediated clustering as previously reported (Kornberg et al., 1991) using antibodies immobilized on magnetic beads. Results in Figure 7A show that VLA-2 clustering with the MEP17 antibody induced an inhibition of about 25% of the T2EC proliferation rate. This eect was speci®c since it was not observed with an isotype matched control antibody or with the 4M12 antibody recognizing an epitope whose expression is not modi®ed by v-erbA. This inhibition was not associated with a proportional increase in cell death ( Figure 7B ) and is similar to decrease aecting the cell number (not shown). Surprisingly, the cross-linking of all b1 integrins with the JG22 antibody reproduced the VLA-2 proliferation inhibition at a quite similar level ( Figure 7A ) despite their higher expression level (see Figure 1 ). When T2EC were infected with XJ12 the sensitivity to the MEP17 induced inhibition was decreased while the non-speci®c inhibitions obtained with the control antibody were identical in uninfected and in infected T2EC ( Figure 7C ). It is of note, however, that the proliferation of XJ12 infected T2EC was still inhibited by b1 clustering with the JG22 antibody and with an intensity that was increased in comparison with that observed on control cells. Taken together these results con®rm that the VLA-2 integrin plays a major role in the control of T2EC proliferation and that v-erbA abrogates this pathway while the b1 signaling pathway was still present.
Discussion
Our results demonstrate for the ®rst time the involvement of VLA-2, a member of the b1-integrin family, in erythropoiesis and describe two aspects of this control. Firstly, VLA-2 expressed by chicken erythrocytic progenitors allows their interaction with Figure 6 Type I collagen inhibits the proliferation of T2EC. Proliferation studies were performed as described in Materials and methods in wells coated with type I collagen or heat denatured BSA as control (both at 20 mg/ml). Blocking antibodies were incubated with cells 1 h in the de®nitive medium before transfer of the mixture into coated wells. MEP17 and JG22 antibodies were used as competitors at 10 mg/ml each, mouse myeloma IgG1 (Control Ab, 10 mg/ml) was used as control. Per cent of inhibition was calculated relative to the maximal proliferation obtained in uncoated wells and in the absence of antibodies. Results presented are the means+s.e.m. of four separate experiments T2EC used in this study are a population of immature chicken erythrocytic progenitors (Gandrillon et al., 1999) . Previous studies of erythrocytic progenitors from mammals described an interaction with type I collagen that was integrin independent (Koenigsmann et al., 1992; Goltry and Patel, 1997) . Our results are in apparent contradiction with these data regarding the involvement of an integrin (Koenigsmann et al., 1992) . The most probable explanation for these con¯icting data is that the TGFa and/or the TGFb used to induce self-renewal of our cells may have increased expression of VLA-2, as occurs in other cell types Chen et al., 1993) . Thus, conditions may have been optimized to observe the involvement of this integrin. However, TGFb has not been reported to induce the inappropriate expression of alpha subunits by these cells , and the in vitro conditions we used mimic the situation in vivo. TGFa and TGFb are major regulators of the selfrenewal of erythrocyte progenitors (Pain et al., 1991; Gandrillon et al., 1999) and TGFb is produced by an autocrine pathway (Gandrillon et al., 1999) . It is thus probable that these factors are abundant in the natural microenvironment of erythrocytic progenitors where they act to induce the expression of VLA-2 in these Figure 8 Schematic summary of the data. The proliferation of normal T2EC is inhibited by engagement of the membrane expressed VLA-2 integrin. As a consequence the number of cells undergoing dierentiation is decreased. The transformation of T2EC by v-erbA locks them into the self-renewal program and decreases the membrane expression of VLA-2 jointly with the VLA-2 brake on cell proliferation Figure 7 The clustering of VLA-2 and of b1-integrins inhibits the proliferation of self-renewing T2EC. (A) The VLA-2 integrin and the b1-integrins were activated by clustering using beads coated with the MEP17 (anti-a2) and the JG22 (anti-b1) antibodies respectively. The 4M12 antibody (Ab) recognizing an antigen expressed by T2EC but not modulated by v-erbA and mouse myeloma IgG1 (Control Ab) were used as control. The cells were incubated with beads before transfer into microplates wells for culture. The proliferation rate was measured by tritiatedthymidine incorporation on 48 h cultures and the value obtained for cells incubated with uncoated beads was considered as the maximal value for the calculation of per cent inhibition. The mean proliferation inhibition+s.e.m. of seven separate experiments is represented. (B) The per cent of dead cells was measured by trypan blue dye incorporation in the same experiments as in (A). (C) Clustering experiments were performed with MEP17 and JG22 antibodies and with mouse myeloma IgG1 as control on uninfected T2EC or on T2EC infected with a virus expressing verbA alone (XJ12) or a mutated form of v-erbA (S61G) used as control virus. Proliferation inhibition, calculated as described in (A), represent the means+s.e.m. of four independent experiments. Proliferation inhibition by MEP17 on XJ12 infected T2EC is signi®cantly dierent from that observed in uninfected T2EC as judged by two-tailed t test (P50.05)
VLA-2 and v-erbA in erythrocytic progenitor proliferation A Mey et al cells in vivo. On the contrary, the culture conditions used in previous studies to isolate mammalian hematopoietic progenitors (Koenigsmann et al., 1992; Goltry and Patel, 1997) may have repressed the natural expression of VLA-2 within the small proportion represented by erythrocytic progenitors in these mixtures. We show here however that adhesion is not the only function of this interaction and that VLA-2 may be involved in the programming of erythrocytic progenitor proliferation during their maturation. Engagement of VLA-2, either by clustering using monoclonal antibodies or by culture of erythrocytic progenitors on type I collagen, led to a decrease in the proliferation rate. This inhibition was neither associated with an increase of cell death, nor associated with a commitment toward dierentiation since we also observed that VLA-2 clustering inhibited the number of cells undergoing dierentiation without a compensatory increase in the number of undierentiated progenitor cells when cultivated in a dierentiation-inducing medium (data not shown). Taken together, these data suggest that type I collagen, through interaction with VLA-2, controls the erythrocytic progenitor pool in a lineagespeci®c manner. A schematic summary of the data is presented in Figure 8 .
Two other integrins belonging to the b1 family and interacting with ®bronectin, VLA-4 and VLA-5, have been demonstrated in vivo and in vitro to control the proliferation of erythropoietic progenitors (Yanai et al., 1994; Hamamura et al., 1996; Arroyo et al., 1999) in a way that has recently been shown to be dependent on IL-3 and SCF concentrations (Jiang et al., 2000) . In our culture conditions the activity of b1 integrins mimicked by clustering with an anti-b1 antibody is mainly oriented toward a limitation of the erythrocytic progenitor number, a situation that may exist in some compartment of the bone marrow. In this context VLA-2 appears to be a major integrin in regulating the proliferation of T2EC since its clustering with the MEP17 antibody achieved inhibition with an eciency similar as that obtained by clustering of the whole b1 integrins with an anti-b1 antibody.
Finally we show here that the expression of the VLA-2 gene is decreased by the v-erbA oncogene. VerbA has been reported to repress the expression of three erythroid speci®c genes namely those coding for the carbonic anhydrase II (Pain et al., 1990) , for the avian erythrocyte anion transporter band 3 and for the delta-aminolevulinate synthase (Zenke et al., 1988) . We observed here that the down-modulation of VLA-2 by the v-erbA oncogene in transformed T2EC led to a decrease of the interaction with type I collagen associated with the abrogation of the VLA-2 brake to the proliferation rate. These eects may account for the induction of proliferation by v-erbA in vitro (Gandrillon et al., 1989; Bauer et al., 1997) and for the massive release of leukemic erythrocytic progenitors from the bone marrow into the circulation in chicken infected with AEV (Graf and Beug, 1978) . It is of note that the b1 transduction pathway can still be activated by b1 clustering in T2EC expressing v-erbA (Figure 7 ). This indicates that the down regulation of VLA-2 is not a consequence of a global b1 down regulation.
V-erbA, as a mutated form of the c-erbA receptor for the thyroid hormone T3, is supposed to act as an antagonist for this receptor on some target genes. The precise mechanism of v-erbA blockade remains to be explored, however it is dicult to explain our data by evoking VLA-2 as a T3 target gene for three reasons. Firstly, we failed to detect any modulation of the VLA-2 membrane expression on T2EC cultivated in the presence of an excess of T3 or in the presence of a blocking anti-T3 antibody (not shown). Secondly, mammalian erythroid progenitors respond to T3 (Dainiak et al., 1978; Dinnen et al., 1994) and this hormone is always present in the serum. If T3 up-regulates VLA-2 expression, in contrast to v-erbA it would induce cultivated mammalian erythroid progenitors to express VLA-2 and to bind collagen, but as evoked above it is not the case. Thirdly, the S61G mutant for v-erbA that is unable to block transcription mediated by retinoic acid receptors but still works as a transdominant inhibitor against T3 receptors failed to repress VLA-2 expression. All these observations suggest that the expression of the VLA-2 gene is controlled by other factors than T3, and that this pathway is also altered by v-erbA. This is consistent with the observation that v-erbA also interfere with pathways controlled by other nuclear hormone receptors Bauer et al., 1997) .
In conclusion, this work unveils a new potential target gene repressed by the v-erbA oncoprotein and points out a new control pathway of erythrocytic progenitor proliferation through the VLA-2 integrin and its interaction with collagen I. In the light of the strong ability of integrins to cooperate with receptors belonging to other families or reacting with other ligands, the role of VLA-2 in vivo has now to be explored.
Materials and methods
Erythrocytic progenitors cultures
Fertilized Spafas eggs were purchased from Lohmann Tierzucht (Cuxhaven, Germany) and T2EC isolated from the bone marrow of 17 day old chicken embryos as previously described (Gandrillon et al., 1999) . Cells were cultivated and ampli®ed in LM1 medium (a-MEM medium (Gibco ± BRL, Life Technologies, Cergy Pontoise, France), 10% FBS (Gibco ± BRL and Biowest, Boehringer Mannheim, Meylan, France), 10 74 M b-mercaptoethanol (Sigma, St. Louis, MO, USA), 5 ng/ml TGFa, 1 ng/ml TGFb1 (R&D Systems, Oxon, UK), 10 76 M dexamethasone (Sigma), 10 73 HEPES (Biomedia, Boussens, France) and 1% of a 1006penicillin plus streptomycin solution (Biomedia)). All cultures were performed at 378C in a 5% CO 2 atmosphere.
Retroviral infection of T2EC
The Neo R expressing retroviruses TXN, XJ12 and S61G were used. TXN expresses the Neo R gene only, XJ12 coexpresses v-erbA (Gandrillon et al., 1987; Benchaibi et al., 1989) and S61G coexpresses a mutant version of v-erbA containing a point mutation in its DNA binding domain (Bonde et al., 1991) . The production of the AEV strain ES4 expressing verbA and v-erbB has been described elsewhere (Gandrillon et al., 1987) . Infections were performed by incubating T2EC for 30 min at 48C and subsequently for 30 min at room temperature with culture supernatants of infected T2EC or chicken embryo ®broblasts. Cells infected with Neo R expressing viruses were then selected in the presence of 0.5 mg/ml Geneticin G418 (Boehringer Mannheim) for 3 days followed by 3 more days with 6 mg/ml G418. AEV infected cells were similarly selected after culture in LM1 without TGFa and TGFb. The resistant infected cells were separated from dead cells and debris by centrifugation through a density gradient on LSM (ICN, Aurora, OH, USA). After washing, the cells were ampli®ed by culture in LM1.
Antibodies and adhesive proteins
The MEP17 monoclonal antibody (McNagny et al., 1992) against the chicken a2 integrin subunit was described earlier (Bradshaw et al., 1995) . Edman sequence analysis of peptides immunoprecipitated with MEP17 gave the following results: KYFQQGGDLTNTFNxxxYxR/K which is homologous to a2, KTVMPYISTTPAK which is homologous to b-1, KMNAK which is homologous to b-1, KIGAAEK which is homologous to b-1. The MC-4M12-26 antibody was provided by Dr H Beug (Institute of Molecular Pathology, Wien, Austria). The JG22 hybridoma (Greve and Gottlieb, 1982) anti-chicken b1-integrin subunit (Buck et al., 1986) was obtained from the Developmental Studies Hybridoma Bank (University of Iowa, IO, USA). Mouse myeloma IgG1 were purchased from Zymed (San Francisco, CA, USA) and were used as control immunoglobulins of the same isotype as MEP17 and JG22 antibodies. For competition experiments antibodies were used as solutions of puri®ed immunoglobulins. Human ®bronectin was purchased from Becton Dickinson (Bedford, MA, USA). Collagen S from calf skin, consisting mainly of type I collagen (95%), was from Boehringer Mannheim. Poly-L-lysine (30 ± 70 kDa) and bovine serum albumin (BSA) were from Sigma.
Chick DNA probes
A chick integrin a2 cDNA (2.2 kb insert) was isolated from a lambda-zap library using the PCR fragment described in Cann et al., 1996 . The sequences used for the speci®c PCR ampli®cation of a 791 bp fragment of the a2 integrin subunit cDNA were TCCAGAACTCAAAAACAGGAGG (sense) and GAAGCCCACCTGTGACATTTCC (anti-sense). The identity of the PCR product was con®rmed by sequencing and homology with the human sequence (Takada and Hemler, 1989) . The primers used for the ampli®cation of a 273 bp fragment of chicken GAPDH were CTGTCCATGCCATCA-CAGCCACAC (sense) and TCAGCAGCAG CCTTCAC-TACCCTC (anti-sense) as previously described (Stone et al., 1985) . Ampli®cation conditions were 948C, 5 min ± 10 cycles (948C, 30 s; 708C, 30 s; 728C, 1 min) ± 30 cycles (948C, 30 s; 558C, 30 s; 728C, 1 min) ± 728C 10 min ± 48C.
Ribonuclease protection assay
The RNA was analysed by a ribonuclease protection assay using the RPA III kit from Ambion (Austin, TX, USA) following the manufacturer's instructions. Brie¯y, anti-sense RNA probes were made by transcription in the presence of a-32 P-UTP/CTP (Amersham Pharmacia) from PCR ampli®-cation products (see above for a2-integrin subunit and GAPDH) cloned in PGEMT easy vectors (Promega, Madison, WI, USA). RNAs from TXN or XJ12 infected T2EC (20 mg) were hybridized with 30 000 c.p.m. of probe for 14 h at 508C. After ribonuclease digestion protected probes were separated by migration in a 5% denaturing polyacrylamide gel that was subsequently exposed for uorography.
Clustering experiments
MEP17, JG22 or control IgG1 coated magnetic beads were prepared following the provider's instructions using 75 ng of mouse IgG for 1610 6 goat anti-mouse IgG coated Dynabeads M-450 (Dynal, Oslo, Norway). For clustering experiments, coated beads were suspended in the proliferation or the dierentiation medium and mixed with the cells in the same medium in a ratio of six beads per cell. The mixture was incubated for 30 min at room temperature on a rotating device before deposing it into microplates for incubation.
Proliferation studies
T2EC were plated in duplicates in 96 well plates at 1610 5 cells /200 ml and cultivated for 48 h. Twenty hours before the end of the culture 0.5 mCi of [ 3 H]thymidine (Amersham Pharmacia Biotech) were added to each well. The mitogenic response was measured by [ 3 H]-thymidine incorporation as previously described (Mey and Revillard, 1998) using a Wallac Microbeta Trilux counter (Perkin Elmer). When proliferation was measured on matrix proteins, collagen and ®bronectin were coated as indicated below but no saturation was performed. For competition experiments the cells were preincubated for 1 h at room temperature under rotating device with the antibodies used as a puri®ed Ig solution at the indicated concentration before measure of the mitogenic response. The antibodies were leaved with the cells during incubation with the matrix proteins.
Measure of cell death
Cell death was measured after Trypan blue incorporation and counting under a microscope. This method gave results in more than three experiments comparable to the propidium iodide incorporation measured by¯ow cytometry and was therefore the most commonly used.
Flow cytometry analysis
Cell surface antigens were detected by incubation of T2EC on ice with saturating concentrations of antibody diluted in PBS plus 1% BSA for 30 min. After washing at 48C, FITClabeled goat anti-mouse antibody (Jackson ImmunoResearch, West Grove, PA, USA) was added as the secondary antibody for 30 min on ice. The cells were ®xed with 3.7% formaldehyde in PBS. The¯uorescence was measured using VLA-2 and v-erbA in erythrocytic progenitor proliferation A Mey et al a FACScan¯ow cytometer (Becton Dickinson) and data were analysed using the CELLQuest program.
Adhesion assay
Proteins (®bronectin or type I collagen) were diluted in water at the indicated concentrations and 100 ml were distributed in triplicates in 96 well plates. Poly-L-lysine was used at 40 mg/ ml and was considered as the coating giving the maximal retention of cells by charge interactions. Coating was performed overnight at 48C. After blocking with PBS plus 0.1% BSA, the cell suspension (100 ml T2EC at 3610 6 /ml aMEM) was added and incubated 45 min at 378C. After washing with PBS the adherent cells were ®xed for 30 min with 1% glutaraldehyde in PBS. The cells were stained with 0.1% crystal-violet, extensively washed with water and subsequently treated with 0.2% Triton in water. Absorbance was measured at 570 nm with an ELISA-reader. For competition experiments the cells were preincubated 1 h at room temperature on a rotative device with the competitor at the indicated concentration before this mixture of cells and competitor was incubated with the substrate.
